Merck & Co Inc (MRK)
Price: $32.93
Industry: Drugs Chaikin Power Gauge Report | Generated: Thu Sep 08 17:09 EDT 2011 MRK Merck & Co Inc
$32.93
Power Gauge Rating
MRK - Neutral TM
The Chaikin Power Gauge Rating for MRK is neutral with average financial metrics, weak earnings performance, bullish price/volume activity and very positive expert opinions.
Financial Metrics
Expert opinions about MRK are very positive which is evidenced by a very low short interest ratio.
Earnings Performance
MRK's earnings performance is weak as a result of a relatively poor trend in earnings this year.
Price/Volume Activity
Expert Opinions
Despite these bullish factors, Chaikin Power Tools has identified a negative trend resulting in a neutral rating.
News Sentiment Rating
Neutral MRK Merck & Co Inc
August 24, 2011
TM
Chaikin Sentiment Gauge for MRK is neutral. Stories concerning MRK have a balanced or neutral sentiment.
News Sentiment :Neutral
Power Trend - 5 Year Chart
The Power Gauge distills a 20 factor model into a concise picture of a stock's potential.
I want to receive special offers about trading stocks with your brokerage partner, optionsXpress. Click here
High Potential
Neutral
Low Potential
www.chaikinpowertools.com
Financials & Earnings
Financial Metrics
Financial Metrics Rating
Neutral
LT Debt/Equity Ratio
MRK's financial metrics are neutral. The company has high revenue per share and is carrying too much long term debt.
Price to Book Value
The rank is based on a high long term debt to equity ratio, low price to sales ratio and relatively low cash flow.
Return on Equity
Price to Sales Ratio
Business Value
Assets and Liabilities
Valuation
Returns
Ratio
TTM
Ratio
TTM
Ratio
Current Ratio
2.05
Price/Book
1.76
Return on Invest
15.4%
LT Debt/Equity
0.27
Price/Sales
2.21
Return on Equity
19.5%
Earnings Performance
TTM
Earnings Performance Rating
Bearish
Earnings Growth
MRK's earnings performance has been weak. The company experienced relatively poor earnings growth in the past 12 months and is priced relatively high compared to next year's projected EPS.
Earnings Surprise
Earnings Trend
The rank is based on high earnings growth over the past 3-5 years, a relatively poor trend in earnings this year, a relatively high projected P/E ratio and consistent earnings over the past 5 years.
Projected P/E Ratio
Earnings Consistency
5 Year Revenue and Earnings Growth
Revenue(M) Rev % Growth EPS EPS % Growth
EPS Estimates
12/06
12/07
12/08
12/09
12/10
22,636.00
24,197.70
23,850.30
27,428.30
45,987.00
2.84%
6.90%
-1.44%
15.00%
67.66%
$2.03
$1.49
$3.64
$5.65
$0.28
-3.33%
-26.60%
144.30%
55.22%
-95.04%
EPS Surprise
Factor
Actual EPS Prev
EST EPS Current
Change
$0.11
$0.90
+0.79
Quarterly EPS Yearly EPS Factor
$0.28
$3.73
+3.45
Actual EPS Growth
Est EPS Growth
Change
18.19%
3.25%
-14.94
3-5 year EPS
EPS Quarterly Results Estimate
Actual
Difference
% Difference
FY
Qtr 1
Qtr 2
Qtr 3
Latest Qtr
$0.95
$0.95
$0.00
1 Qtr Ago
$0.84
$0.92
$0.08
2 Qtr Ago
$0.83
$0.88
3 Qtr Ago
$0.83
$0.85
0.00
12/09
$0.68
$0.74
9.52
12/10
$0.09
$0.24
$0.05
6.02
12/11
$0.34
$0.65
$0.02
2.41
Fiscal Year End Month is December.
I want to receive special offers about trading stocks with your brokerage partner, optionsXpress. Click here
Qtr 4
Total
$1.61
$2.35
$5.38
$0.11
$-0.17
$0.27
-
-
-
www.chaikinpowertools.com
Price Trend & Expert Opinions Price/Volume Activity
Price/Volume Activity Rating
Bullish
Relative Strength vs Market
Chaikin Money Flow
Price and volume activity for MRK is bullish. MRK has outperformed the S&P 500 over 26 weeks and has a rising price trend.
Price Trend
The rank for MRK is based on its price strength versus the market, negative Chaikin money flow, a positive Chaikin price trend, a negative Chaikin price trend ROC and an increasing volume trend.
Price Trend ROC
Volume Trend
Relative Strength vs S&P500 Index
Chaikin Money Flow
Chart shows whether MRK is performing better or worse than the market.
Chaikin Money Flow analyzes supply and demand for a company's stock.
Price Activity
Price Activity
Volume Activity
Factor
Value
Factor
52 Week High
37.58
% Change Price - 4 Weeks
10.57%
Average Volume 20 Days
16,385,914
52 Week Low
29.81
% Change Price - 24 Weeks
1.01%
Average Volume 90 Days
15,104,853
% Change Price - 4 Wks Rel to S&P
3.38%
Chaikin Money Flow Persistency
% Change Price - 24 Wks Rel to S&P
9.35%
% Change YTD Rel S&P 500
-3.78%
Expert Opinions
Value
Factor
Value
34%
Expert Opinions
Very Bullish
Earnings Estimate Revisions
Expert opinions about MRK are very positive. Shorting of MRK is low and analysts's opinions on MRK have been more positive recently.
Short Interest
Insider Activity
The rank for MRK is based on a low short interest ratio, insiders purchasing stock, optimistic analyst opinions and price strength of the stock versus the Drugs industry group.
Analyst Opinions
Relative Strength vs Industry
Earnings Estimate Revisions Current Current Qtr Next Qtr
0.90 0.96 Current
Current FY
3.73
Analyst Recommendations
7 Days Ago % Change 0.90 0.96
0.00% 0.00%
30 Days Ago % Change 3.73
0.00
Factor Mean this Week Mean Last Week
EPS Estimates Revision Summary Value
Buy 0.00
Mean 5 Weeks Ago
Buy
Last 4 Weeks
Down
Up
Down
Curr Qtr
0
0
0
0
Curr Yr
0
0
0
2
Next Qtr
0
0
0
0
Next Yr
0
0
0
2
Buy
Change
I want to receive special offers about trading stocks with your brokerage partner, optionsXpress. Click here
Last Week Up
www.chaikinpowertools.com
The Company & Its Competitors
News Headlines for MRK
MRK's Competitors in Drugs Company
Power Gauge
Orasure Technologies reports second-quarter loss - Aug 4, 2011
Historic EPS growth
Projected EPS growth
Profit Margin
PEG
PE
Revenue(M)
MRK
18.19%
3.25%
6.13%
2.72
9.16
45,987
FeminaPharma NuvaRing 08 02 - Aug 2, 2011
JNJ
4.21%
6.00%
18.32%
2.20
13.38
61,587
Merck's Wilson plant adding jobs - Aug 1, 2011
NVS
9.55%
4.71%
18.05%
2.16
10.62
50,624
Earnings Preview: Bristol-Myers reports 2Q results - Jul 26, 2011
PFE
6.66%
4.00%
12.78%
2.12
8.60
67,809
SNY
4.26%
1.30%
16.81%
5.61
8.76
41,395
GSK
3.26%
4.82%
11.92%
2.36
11.70
45,905
Femina NuvaRing 07 20 - Jul 20, 2011
Company Details
Company Profile
MERCK & CO INC ONE MERCK DRIVE P.O. BOX 100 WHITEHOUSE STATION, NJ 08889-0100 USA Phone: 908-423-4840 Fax: 908-298-7082 Website: http://http://www.merck.com Full Time Employees: 94,000 Sector: Medical
Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The company devotes extensive efforts to increase access to medicines through far-reaching programs that not only donate Merck medicines but help deliver them to the people who need them. Merck also publishes unbiased health information as a not-for-profit service.
Power Gauge Ratings are created using a relative ranking system that assigns a rank of 0 to 100 (100 being the highest) to each stock in the universe. Rank is calculated by evaluating each of the stocks factors and combining them into a single number using a weighting formula. A stock's rank ranges from 100-0, where 100 is the strongest, and a rank of 95 indicates the stock is better than 95% of the stocks in the universe. Chaikin Stock Research(CSR) is not registered as a securities broker dealer or investment advisor with either the U.S. Securities and Exchange Commission or with any state securities regulatory authority. CSR is not responsible for trades executed by users of this research report, our web site or mobile app based on the information included herein. The information presented in this report does not represent a recommendation to buy or sell stocks or any financial instrument nor is it intended as an endorsement of any security or investment. The information in this report is generic by nature and is not personalized to the specific financial situation of any individual. The user bears complete responsibility for their own investment research and should seek the advice of a qualified investment professional before making any investment decisions. Copyright (c) 1978-(Present) by ZACKS Investment Research, Inc ("ZACKS"). The information, data, analyses and opinions contained herein (1) includes the confidential and proprietary information of ZACKS, (2) may not be copied or redistributed, for any purpose, (3) does not constitute investment advice offered by ZACKS, (4) are provided solely for informational purposes, and (5) are not warranted or represented to be correct, complete, accurate or timely. ZACKS shall not be responsible for investment decisions, damages or other losses resulting from, or related to, use of this information, data, analyses or opinions. Past performance is no guarantee of future performance. ZACKS is not affiliated with Chaikin Power Tools. This report from Chaikin Power Tools is for informational purposes only and is not a recommendation to buy or sell securities.
LM 2.3 DS 3.0 LS 2.1
Data Provided by ZACKS Investment Research, Inc., www.zacks.com
Special offers to trade stocks from optionsXpress: www.chaikinpowertools.com